NCT04422327View on ClinicalTrials.gov

The Impact of a Combination of Bifidobacterium Longum 35624® and 1714™ Strains in Adults With Irritable Bowel Syndrome

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 20, 2017

Primary Completion Date

February 12, 2018

Study Completion Date

February 12, 2018

Conditions
IBS - Irritable Bowel SyndromeDepression, Anxiety
Interventions
DIETARY_SUPPLEMENT

Probiotic capsule

"Each probiotic capsule contains 5 x 10\^8 CFU B. longum 35624® and 5 x 10\^8 CFU B. longum 1714™ with corn starch and magnesium stearate.~The probiotic capsule will be supplied by PrecisionBiotics Ltd."

Trial Locations (1)

Unknown

Atlantia Food Clinical Trials Ltd., Cork

Sponsors
All Listed Sponsors
collaborator

Atlantia Food Clinical Trials

INDUSTRY

lead

PrecisionBiotics Group Ltd.

INDUSTRY